NSCLC management

Rudolf M. Huber (Germany)

Source: ERS Course 2019 - Summer school of adult respiratory medicine
Number: 11

PDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Rudolf M. Huber (Germany). NSCLC management. ERS Course 2019 - Summer school of adult respiratory medicine

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
SCLC management
Source: ERS Course 2019 - Summer school of adult respiratory medicine
Year: 2019

SCLC management
Source: ERS Skills Course 2017 - Summer school of adult respiratory medicine
Year: 2017

SCLC management
Source: ERS Course 2018 - Summer school of adult respiratory medicine
Year: 2018

Treatment of patients with advanced non-small-cell lung cancer (NSCLC) with erlotinib: results from clinical practice
Source: Annual Congress 2008 - Therapy of thoracic tumours
Year: 2008


The method of individualisation of treatment and prognosis for advanced non-small cell lung cancer
Source: Annual Congress 2010 - Prognostic factors for lung cancer
Year: 2010

Interdisciplinary multimodality management of stage III nonsmall cell lung cancer
Source: Eur Respir Rev, 28 (152) 190024; 10.1183/16000617.0024-2019
Year: 2019



Current status of and future strategies for multimodality treatment of unresectable stage III nonsmall cell lung cancer
Source: Eur Respir J 2013; 42: 1119-1133
Year: 2013



The role of palliative radiotherapy in locally advanced non small cell lung cancer
Source: Annual Congress 2007 - Therapy of lung cancer
Year: 2007



Results of surgical treatment in elderly patients with non-small cell lung cancer (NSCLC)
Source: Eur Respir J 2002; 20: Suppl. 38, 463s
Year: 2002

Towards personalized treatment in non-small-cell lung carcinoma
Source: Virtual Congress 2020 – Management issues in thoracic oncology
Year: 2020


Should patients with metastatic NSCLC and poor performance status be treated by chemotherapy?
Source: Annual Congress 2007 - Treatment of metastatic nonsmall cell lung cancer in the era of targeted therapies
Year: 2007


Treatment of advanced non-small cell lung cancer
Source: Annual Congress 2005 - PG2 - Lung cancer: non-small cell lung cancer treatment
Year: 2005


Surgical multimodality treatment for stage III non-small cell lung cancer (NSCLC)
Source: Annual Congress 2006 - Integrative approaches for stage III non-small cell lung cancer
Year: 2006


Therapeutic management of ALK+ nonsmall cell lung cancer patients
Source: Eur Respir J 2015; 46: 230-242
Year: 2015



Customising chemotherapy in advanced nonsmall cell lung cancer: daily practice and perspectives
Source: Eur Respir Rev 2011; 20: 45-52
Year: 2011



Management of patients with non-small-cell lung cancer
Source: ERS Live 2007
Year: 2007